"Designing Growth Strategies is in our DNA"

Cardiac Biomarkers Market Size, Share & Industry Analysis, By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Others), By Biomarker (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101233

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Cardiovascular Disorders, By Key Regions/ Key Countries, 2019
    2. Overview of Impact of COVID-19 on the In-vitro Diagnostics Market
    3. New Product Launches, By Key Market Players
    4. Key Industry Developments such as Mergers and Acquisitions
    5. Key Steps Taken by Companies, Government, etc. to Navigate the Impact of Covid-19
    6. Overview: Impact of Covid-19 on Cardiac Tests
  5. Global Cardiac Biomarkers Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    3. Market Analysis, Insights and Forecast – By Biomarkers
      1. Troponin
      2. Creatine kinase-MB (CK-MB)
      3. B-type natriuretic peptide (BNP)
      4. Myoglobin
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Speciality Clinics
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Cardiac Biomarkers Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    3. Market Analysis, Insights and Forecast – By Biomarkers
      1. Troponin
      2. Creatine kinase-MB (CK-MB)
      3. B-type natriuretic peptide (BNP)
      4. Myoglobin
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Speciality Clinics
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Cardiac Biomarkers Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    3. Market Analysis, Insights and Forecast – By Biomarkers
      1. Troponin
      2. Creatine kinase-MB (CK-MB)
      3. B-type natriuretic peptide (BNP)
      4. Myoglobin
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Speciality Clinics
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Cardiac Biomarkers Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    3. Market Analysis, Insights and Forecast – By Biomarkers
      1. Troponin
      2. Creatine kinase-MB (CK-MB)
      3. B-type natriuretic peptide (BNP)
      4. Myoglobin
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Speciality Clinics
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Cardiac Biomarkers Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    3. Market Analysis, Insights and Forecast – By Biomarkers
      1. Troponin
      2. Creatine kinase-MB (CK-MB)
      3. B-type natriuretic peptide (BNP)
      4. Myoglobin
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Speciality Clinics
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Cardiac Biomarkers Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    3. Market Analysis, Insights and Forecast – By Biomarkers
      1. Troponin
      2. Creatine kinase-MB (CK-MB)
      3. B-type natriuretic peptide (BNP)
      4. Myoglobin
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Speciality Clinics
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, and Financials (based on availability))
      1. F. Hoffmann-La Roche AG
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Abbott
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Siemens AG
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Creative Diagnostics
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Beckman Coulter, Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      8. bioMérieux SA
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1: Global Cardiac Biomarkers Market Revenue Breakdown (USD Bn, %) by Region, 2019 & 2027

Figure 2: Global Cardiac Biomarkers Market Value Share (%), by Indication, 2019 & 2027

Figure 3: Global Cardiac Biomarkers Market Forecast (USD Bn), by Myocardial Infarction, 2016-2027

Figure 4: Global Cardiac Biomarkers Market Forecast (USD Bn), by Congestive Heart Failure, 2016-2027

Figure 5: Global Cardiac Biomarkers Market Forecast (USD Bn), by Acute Coronary Syndrome, 2016-2027

Figure 6: Global Cardiac Biomarkers Market Forecast (USD Bn), by Others, 2016-2027

Figure 7: Global Cardiac Biomarkers Market Value Share (%), by Biomarker, 2019 & 2027

Figure 8: Global Cardiac Biomarkers Market Forecast (USD Bn), by Troponin, 2016-2027

Figure 9: Global Cardiac Biomarkers Market Forecast (USD Bn), by Creatine kinase-MB (CK-MB), 2016-2027

Figure 10: Global Cardiac Biomarkers Market Forecast (USD Bn), by B-type natriuretic peptide (BNP), 2016-2027

Figure 11: Global Cardiac Biomarkers Market Forecast (USD Bn), by Myoglobin, 2016-2027

Figure 12: Global Cardiac Biomarkers Market Forecast (USD Bn), by Others, 2016-2027

Figure 13: Global Cardiac Biomarkers Market Value Share (%), by End User, 2019 & 2027

Figure 14: Global Cardiac Biomarkers Market Forecast (USD Bn), by Hospitals, 2016-2027

Figure 15: Global Cardiac Biomarkers Market Forecast (USD Bn), by Speciality Clinics, 2016-2027

Figure 16: Global Cardiac Biomarkers Market Value (USD Bn), by Region, 2019 & 2027

Figure 17: North America Cardiac Biomarkers Market Value (USD Bn), by Indication, 2019 & 2027

Figure 18: North America Cardiac Biomarkers Market Value Share (%), by Indication, 2019

Figure 19: North America Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2019 & 2027

Figure 20: North America Cardiac Biomarkers Market Value Share (%), by Biomarker, 2019

Figure 21: North America Cardiac Biomarkers Market Value (USD Bn), by End User, 2019 & 2027

Figure 22: North America Cardiac Biomarkers Market Value Share (%), by End User, 2019

Figure 23: North America Cardiac Biomarkers Market Value (USD Bn), By Country, 2019 & 2027

Figure 24: North America Cardiac Biomarkers Market Value Share (%), By Country, 2019

Figure 25: Europe Cardiac Biomarkers Market Value (USD Bn), by Indication, 2019 & 2027

Figure 26: Europe Cardiac Biomarkers Market Value Share (%), by Indication, 2019

Figure 27: Europe Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2019 & 2027

Figure 28: Europe Cardiac Biomarkers Market Value Share (%), by Biomarker, 2019

Figure 29: Europe Cardiac Biomarkers Market Value (USD Bn), by End User, 2019 & 2027

Figure 30: Europe Cardiac Biomarkers Market Value Share (%), by End User, 2019

Figure 31: Europe Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 32: Europe Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2019

Figure 33: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), by Indication, 2019 & 2027

Figure 34: Asia Pacific Cardiac Biomarkers Market Value Share (%), by Indication, 2019

Figure 35: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2019 & 2027

Figure 36: Asia Pacific Cardiac Biomarkers Market Value Share (%), by Biomarker, 2019

Figure 37: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), by End User, 2019 & 2027

Figure 38: Asia Pacific Cardiac Biomarkers Market Value Share (%), by End User, 2019

Figure 39: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 40: Asia Pacific Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2019

Figure 41: Latin America Cardiac Biomarkers Market Value (USD Bn), by Indication, 2019 & 2027

Figure 42: Latin America Cardiac Biomarkers Market Value Share (%), by Indication, 2019

Figure 43: Latin America Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2019 & 2027

Figure 44: Latin America Cardiac Biomarkers Market Value Share (%), by Biomarker, 2019

Figure 45: Latin America Cardiac Biomarkers Market Value (USD Bn), by End User, 2019 & 2027

Figure 46: Latin America Cardiac Biomarkers Market Value Share (%), by End User, 2019

Figure 47: Latin America Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 48: Latin America Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2019

Figure 49: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), by Indication, 2019 & 2027

Figure 50: Middle East & Africa Cardiac Biomarkers Market Value Share (%), by Indication, 2019

Figure 51: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2019 & 2027

Figure 52: Middle East & Africa Cardiac Biomarkers Market Value Share (%), by Biomarker, 2019

Figure 53: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), by End User, 2019 & 2027

Figure 54: Middle East & Africa Cardiac Biomarkers Market Value Share (%), by End User, 2019

Figure 55: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 56: Middle East & Africa Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2019

Figure 57:   Global Cardiac Biomarkers Market Share (%), By Company, 2019

Table 1: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2016-2027

Table 2: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2016-2027

Table 3: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2016-2027

Table 4: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Region, 2016-2027

Table 5: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2016-2027

Table 6: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2016-2027

Table 7: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2016-2027

Table 8: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country, 2016-2027

Table 9: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2016-2027

Table 10: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2016-2027

Table 11: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2016-2027

Table 12: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 13: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2016-2027

Table 14: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2016-2027

Table 15: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2016-2027

Table 16: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 17: Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2016-2027

Table 18: Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2016-2027

Table 19:  Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2016-2027

Table 20:  Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21: Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2016-2027

Table 22: Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2016-2027

Table 23:  Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2016-2027

Table 24:  Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Cardiac Biomarkers Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports